What We're Reading: Page 32
Industry reads hand-picked by our editors
Mar 11, 2025
-
ProPublica
These Topics Are Being Scrutinized at the National Cancer Institute
-
Yahoo Finance
Multiple authorities investigate alleged arson attack on Bayer executive’s NJ home
-
Fierce Biotech
Coherus to lose 30% of staff as part of Udenyca sale to Accord
-
MedTech Dive
New FDA pulse oximetry guidelines could stall under Trump
Mar 10, 2025
-
The Washington Post
CDC plans study on vaccines and autism despite research showing no link
-
The Financial Times
Hikma races to launch generic versions of blockbuster obesity drugs
-
Bloomberg
Senators Say Kennedy Must Disclose Details on Drugmaker Meetings
Mar 07, 2025
Mar 06, 2025
Mar 05, 2025
-
Associated Press
Trump’s FDA pick made his name by bashing the medical establishment. Soon he may be leading it
-
The Wall Street Journal
New Version of Merck’s Blockbuster Cancer Drug Threatened by Patent Battle
-
Fierce Biotech
DOGE terminates leases for 30 FDA sites across 23 states
-
Nature
Meet the ‘woolly mouse’: why scientists doubt it’s a big step towards recreating mammoths
Previous
